Lung pressure drug trial halted early
NCT ID NCT05339087
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 26 times
Summary
This study tested a drug called riociguat in people with early pulmonary vascular disease, a condition where blood vessels in the lungs are under too much pressure. The goal was to see if the drug could improve blood flow and heart function. The study included 35 adults with connective tissue disease or an inherited form of the condition. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carl Gustav Carus University Hospital at the TU Dresden, Medical Department I, Center for PH
Dresden, Germany
-
Centre de référence des Maladies Auto-Immunes Systémiques rares du Nord et Nord-Ouest (CeRAINO) Service de Médecine Interne et Immunologie Clinique Hôpital Claude Huriez, CHU
Lille, 59037, France
-
Centre for Pulmonary Hypertension at the Thoraxklinik Heidelberg, Heidelberg University Hospital Heidelberg
Heidelberg, 69126, Germany
-
LKH-Univ. Klinikum Graz Universitätsklinik für Innere Medizin Klinische Abteilung für Pulmonologie
Graz, 8036, Austria
-
Ordensklinikum Linz GmbH Elisabethinen
Linz, 4020, Austria
-
Royal Free London NHS Foundation Trust
London, United Kingdom
-
Università Degli Studi Di Napoli Federico II Scuola Di Medicina E Chirurgia
Naples, 80131, Italy
-
Universitätsspital Zürich Pulmonale Hypertonie, Klinik für Pneumologie
Zurich, 8091, Switzerland
Conditions
Explore the condition pages connected to this study.